Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

BACKGROUND: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of current vaccines. METHODS: We used a test-negative case...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrews, Nick, Stowe, Julia, Kirsebom, Freja, Toffa, Samuel, Rickeard, Tim, Gallagher, Eileen, Gower, Charlotte, Kall, Meaghan, Groves, Natalie, O’Connell, Anne-Marie, Simons, David, Blomquist, Paula B., Zaidi, Asad, Nash, Sophie, Iwani Binti Abdul Aziz, Nurin, Thelwall, Simon, Dabrera, Gavin, Myers, Richard, Amirthalingam, Gayatri, Gharbia, Saheer, Barrett, Jeffrey C., Elson, Richard, Ladhani, Shamez N., Ferguson, Neil, Zambon, Maria, Campbell, Colin N.J., Brown, Kevin, Hopkins, Susan, Chand, Meera, Ramsay, Mary, Lopez Bernal, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908811/
https://www.ncbi.nlm.nih.gov/pubmed/35249272
http://dx.doi.org/10.1056/NEJMoa2119451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908811/
https://www.ncbi.nlm.nih.gov/pubmed/35249272
http://dx.doi.org/10.1056/NEJMoa2119451

Ejemplares similares